SCHEMBL21095221

SCHEMBL21095221

Nc1ncc(C(=O)OCc2ccccc2)cn1

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.64
KMT2A Q03164 3/20 0.64
SLC6A2 P23975 1/20 0.64
SLC6A3 Q01959 1/20 0.64
LMNA P02545 3/20 0.59
ALDH1A1 P00352 6/20 0.51
MAPT P10636 3/20 0.51
HPGD P15428 1/20 0.51
KDM4E B2RXH2 2/20 0.49
MAOB P27338 1/20 0.49
ADORA2A P29274 1/20 0.49
POLB P06746 1/20 0.49
RAB9A P51151 3/20 0.48
NPC1 O15118 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
GAA P10253 1/20 0.47
JMJD6 Q6NYC1 1/20 0.46
PRKCZ Q05513 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1712044 0.84 KMT2A (0.60) TDP1KMT2ASLC6A2SLC6A3LMNA
SCHEMBL20305861 0.84 TDP1 (0.64) TDP1KMT2ASLC6A2SLC6A3LMNA
SCHEMBL25469034 0.84 KMT2A (0.64) TDP1KMT2ASLC6A2SLC6A3LMNA
SCHEMBL18542508 0.84 TDP1 (0.64) TDP1KMT2ASLC6A2SLC6A3LMNA
SCHEMBL27503298 0.82 KMT2A (0.45) TDP1KMT2ASLC6A2SLC6A3LMNA
SCHEMBL23351143 0.80 KMT2A (0.71) TDP1KMT2ASLC6A2SLC6A3LMNA
SCHEMBL9287509 0.79 NPC1 (0.43) TDP1KMT2ASLC6A2SLC6A3LMNA
SCHEMBL4886266 0.79 LMNA (0.66) TDP1KMT2ASLC6A2SLC6A3LMNA
SCHEMBL4984363 0.79 KMT2A (0.62) TDP1KMT2ASLC6A2SLC6A3LMNA
SCHEMBL9628165 0.79 KMT2A (0.62) TDP1KMT2ASLC6A2SLC6A3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3082867-B1 ISOXAZOLINE COMPOSITIONS AND USE THEREOF IN THE PREVENTION OR TREATMENT OF PARASITE INFESTATIONS IN ANIMALS INTERVET INT BV (NL) 2024-01-17 EP disclosed
EP-4306168-A2 ISOXAZOLINE COMPOSITIONS AND USE THEREOF IN THE PREVENTION OR TREATMENT OF PARASITE INFESTATIONS IN ANIMALS Intervet International B.V. (NL) 2024-01-17 EP disclosed
EP-4076447-B1 PARASITE CONTROL IN RUMINANTS INTERVET INT BV (NL) 2024-01-17 EP disclosed
EP-4153133-B1 INJECTABLE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF INTERVET INT BV (NL) 2023-11-08 EP disclosed
EP-3878281-B1 USE OF ISOXAZOLINE COMPOUNDS IN POULTRY INTERVET INT BV (NL) 2023-05-24 EP disclosed
EP-2833867-B2 SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR ISOXAZOLINE COMPOUNDS INTERVET INT BV (NL) 2023-05-10 EP disclosed
WO-2022269042-A1 PALATABLE VETERINARY COMPOSITIONS INTERVET INTERNATIONAL B.V. (NL) 2022-12-29 WO disclosed
WO-2022258797-A1 TICK CONTROL METHODS INTERVET INTERNATIONAL B.V. (NL) 2022-12-15 WO disclosed
EP-4008329-A1 ISOXAZOLINE COMPOUNDS FOR USE IN TREATING DEMODICOSIS Intervet International B.V. (NL) 2022-06-08 EP disclosed
EP-2658542-B1 TOPICAL LOCALIZED ISOXAZOLINE FORMULATION INTERVET INT BV (NL) 2022-01-26 EP disclosed
WO-2021233967-A1 INJECTABLE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF INTERVET INTERNATIONAL B.V. (NL) 2021-11-25 WO disclosed
EP-3878281-A1 USE OF ISOXAZOLINE COMPOUNDS IN POULTRY Intervet International B.V. (NL) 2021-09-15 EP disclosed
WO-2021122513-A1 COMPOSITION FOR LICE CONTROL INTERVET INTERNATIONAL B.V. (NL) 2021-06-24 WO disclosed
WO-2021122521-A1 COMPOSITION FOR LICE CONTROL IN POULTRY INTERVET INTERNATIONAL B.V. (NL) 2021-06-24 WO disclosed
WO-2021122515-A1 PARASITE CONTROL IN RUMINANTS INTERVET INTERNATIONAL B.V. (NL) 2021-06-24 WO disclosed
EP-3082806-B1 USE OF ISOXAZOLINE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF ARTHROPOD INFESTATIONS IN POULTRY INTERVET INT BV (NL) 2021-05-12 EP disclosed
WO-2021013825-A1 SOFT CHEWABLE VETERINARY DOSAGE FORM INTERVET INTERNATIONAL B.V. (NL) 2021-01-28 WO disclosed
WO-2020225143-A1 INJECTABLE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF INTERVET INTERNATIONAL B.V. (NL) 2020-11-12 WO disclosed
WO-2019115492-A1 IMPLANTABLE ISOXAZOLINE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF INTERVET INTERNATIONAL B.V. (NL) 2019-06-20 WO disclosed